SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-007307
Filing Date
2021-02-23
Accepted
2021-02-23 08:28:31
Documents
16
Period of Report
2021-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K odt-8k_20210223.htm   iXBRL 8-K 40547
2 EX-1.1 odt-ex11_7.htm EX-1.1 276661
3 EX-5.1 odt-ex51_8.htm EX-5.1 7925
4 GRAPHIC ghvttawffnka000001.jpg GRAPHIC 26743
5 GRAPHIC ghvttawffnka000002.jpg GRAPHIC 30438
  Complete submission text file 0001564590-21-007307.txt   599337

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA odt-20210223.xsd EX-101.SCH 5769
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20210223_lab.xml EX-101.LAB 20214
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20210223_pre.xml EX-101.PRE 12079
9 EXTRACTED XBRL INSTANCE DOCUMENT odt-8k_20210223_htm.xml XML 3683
Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38318 | Film No.: 21663199
SIC: 2834 Pharmaceutical Preparations